Institutional investors hold a majority ownership of PCRX through the 109.34% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2014, these large investors purchased a net $477.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROBERT W. BAIRD & CO., INC. (EQU... Bought 25.2 Thousand shares of Pacira Pharmaceuticals In...